Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 11, 2023
Total Value: $1.564B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| — | Karuna Therapeutics Inc | 1,773,124 | $322M | 20.6% | $181.64 | $32.21 | — | COM | 48576A100 |
| NTRA | Natera Inc | 3,100,560 | $172M | 11.0% | $55.52 * | $9.81 | +389.3% | COM | 632307104 |
| MRK | Merck & Co Inc | 841,522 | $89.53M | 5.7% | $106.39 * | $85.36 | +15.6% | COM | 58933Y105 |
| SPY | SPDR S&P 500 ETF Trust | 200,000 | $81.88M | 5.2% | $409.39 | — | — | Put | 78462F103 |
| ASND | Ascendis Pharma A/S | 754,032 | $80.85M | 5.2% | $107.22 | $92.54 | — | SPONSORED ADR | 04351P101 |
| — | Aerovate Therapeutics Inc | 3,758,686 | $75.81M | 4.8% | $20.17 | $22.83 | — | COM | 008064107 |
| — | Reata Pharmaceuticals Inc | 627,683 | $57.07M | 3.6% | $90.92 | $32.98 | — | CL A | 75615P103 |
| LLY | Eli Lilly and Co | 137,100 | $47.08M | 3.0% | $343.42 * | $329.89 | 0.0% | COM | 532457108 |
| — | Horizon Therapeutics PLC | 408,819 | $44.62M | 2.9% | $109.14 | $113.80 | — | SHS | G46188101 |
| ISRG | Intuitive Surgical Inc | 149,589 | $38.22M | 2.4% | $255.47 * | $246.36 | 0.0% | COM | 46120E602 |
| BIIB | Biogen Inc | 132,600 | $36.87M | 2.4% | $278.03 | $276.70 | 0.0% | COM | 09062X103 |
| BMRN | Biomarin Pharmaceutical Inc | 359,035 | $34.91M | 2.2% | $97.24 * | $84.75 | +22.3% | COM | 09061G101 |
| DXCM | Dexcom Inc | 257,227 | $29.88M | 1.9% | $116.18 * | $101.24 | +10.6% | COM | 252131107 |
| TVTX | Travere Therapeutics Inc | 1,263,721 | $28.42M | 1.8% | $22.49 * | $22.38 | -5.0% | COM | 89422G107 |
| VERA | Vera Therapeutics Inc | 3,467,156 | $26.91M | 1.7% | $7.76 | $15.35 | -49.7% | CL A | 92337R101 |
| PTCT | PTC Therapeutics Inc | 517,095 | $25.05M | 1.6% | $48.44 * | $45.71 | 0.0% | COM | 69366J200 |
| ZNTL | Zentalis Pharmaceuticals Inc | 1,439,062 | $24.75M | 1.6% | $17.20 * | $23.30 | -13.1% | COM | 98943L107 |
| — | Inhibrx Inc | 1,244,488 | $23.48M | 1.5% | $18.87 | $23.93 | — | COM | 45720L107 |
| — | Chinook Therapeutics Inc | 1,002,348 | $23.2M | 1.5% | $23.15 | $23.13 | — | COM | 16961L106 |
| SNDX | Syndax Pharmaceuticals Inc | 1,075,424 | $22.71M | 1.5% | $21.12 * | $21.60 | +15.1% | COM | 87164F105 |
| — | IVERIC bio Inc | 905,982 | $22.04M | 1.4% | $24.33 | $19.06 | — | COM | 46583P102 |
| IMTX | Immatics NV | 3,132,694 | $21.62M | 1.4% | $6.90 * | $9.71 | -15.7% | SHS | N44445109 |
| — | Inozyme Pharma Inc | 3,655,308 | $20.94M | 1.3% | $5.73 | $16.71 | — | COM | 45790W108 |
| GERN | Geron Corp | 8,274,892 | $17.96M | 1.1% | $2.17 * | $2.59 | +9.8% | COM | 374163103 |
| SRPT | Sarepta Therapeutics Inc | 119,065 | $16.41M | 1.0% | $137.83 * | $93.67 | +38.5% | COM | 803607100 |
| EXEL | Exelixis Inc | 831,243 | $16.13M | 1.0% | $19.41 * | $17.42 | 0.0% | COM | 30161Q104 |
| VIR | Vir Biotechnology Inc | 657,559 | $15.3M | 1.0% | $23.27 * | $25.58 | 0.0% | COM | 92764N102 |
| CLDX | Celldex Therapeutics Inc | 419,397 | $15.09M | 1.0% | $35.98 * | $43.15 | 0.0% | COM | 15117B202 |
| — | Prometheus Biosciences Inc | 123,842 | $13.29M | 0.9% | $107.32 | $45.26 | — | COM | 74349U108 |
| CYTK | Cytokinetics Inc | 353,796 | $12.45M | 0.8% | $35.19 * | $39.04 | +4.5% | COM | 23282W605 |
| — | CTI Biopharma Corp | 2,794,542 | $11.74M | 0.8% | $4.20 | $5.40 | — | COM | 12648L601 |
| — | Y-mAbs Therapeutics Inc | 2,194,278 | $10.99M | 0.7% | $5.01 | $26.75 | — | COM | 984241109 |
| — | Agenus Inc | 6,407,457 | $9.739M | 0.6% | $1.52 | $1.77 | — | COM | 00847G705 |
| — | Marinus Pharmaceuticals Inc | 1,200,389 | $8.283M | 0.5% | $6.90 | $6.90 | — | COM | 56854Q200 |
| GRTX | Galera Therapeutics Inc | 3,083,712 | $7.894M | 0.5% | $2.56 * | $12.19 | -83.1% | COM | 36338D108 |
| KURA | Kura Oncology Inc | 616,169 | $7.536M | 0.5% | $12.23 * | $14.46 | -13.7% | COM | 50127T109 |
| AXSM | Axsome Therapeutics Inc | 120,896 | $7.457M | 0.5% | $61.68 * | $65.70 | 0.0% | COM | 05464T104 |
| IDYA | IDEAYA Biosciences Inc | 453,149 | $6.222M | 0.4% | $13.73 * | $12.99 | +28.3% | COM | 45166A102 |
| — | Nucana PLC | 5,599,999 | $5.377M | 0.3% | $0.96 | $9.47 | — | SPONSORED ADR | 67022C106 |
| RVMD | Revolution Medicines Inc | 183,838 | $3.982M | 0.3% | $21.66 * | $24.62 | 0.0% | COM | 76155X100 |
| — | Nextcure Inc | 2,671,856 | $3.954M | 0.3% | $1.48 | $10.01 | — | COM | 65343E108 |
| — | ImmunoGen Inc | 1,000,000 | $3.84M | 0.2% | $3.84 | $5.69 | — | Call | 45253H101 |
| — | Bolt Biotherapeutics Inc | 2,754,437 | $3.829M | 0.2% | $1.39 | $32.91 | — | COM | 097702104 |
| — | ImmunoGen Inc | 924,532 | $3.55M | 0.2% | $3.84 | $5.69 | — | COM | 45253H101 |
| KROS | Keros Therapeutics Inc | 77,100 | $3.292M | 0.2% | $42.70 * | $50.51 | 0.0% | COM | 492327101 |
| NVCR | Novocure Ltd | 50,000 | $3.007M | 0.2% | $60.14 | — | — | Call | G6674U108 |
| — | Nucana PLC | 2,400,000 | $2.304M | 0.1% | $0.96 | $4.99 | — | COMMON SHARES | GB00BYWYV |
| — | bluebird bio Inc | 672,815 | $2.14M | 0.1% | $3.18 | $3.18 | — | COM | 09609G100 |
| PDSB | PDS Biotechnology Corp | 142,635 | $877K | 0.1% | $6.15 * | $8.36 | -2.1% | COM | 70465T107 |
| — | Fusion Pharmaceuticals Inc | 117,099 | $441K | 0.0% | $3.77 | $6.28 | — | COM | 36118A100 |
| — | Synlogic Inc | 574,972 | $363K | 0.0% | $0.63 | $9.38 | — | COM | 87166L100 |
| ALNY | Alnylam Pharmaceuticals Inc | 448 | $89,743 | 0.0% | $200.32 * | $213.29 | -1.5% | COM | 02043Q107 |